Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial.

St Clair EW, Baer AN, Wei C, Noaiseh G, Parke A, Coca A, Utset TO, Genovese MC, Wallace DJ, McNamara J, Boyle K, Keyes-Elstein L, Browning JL, Franchimont N, Smith K, Guthridge JM, Sanz I, James JA; Autoimmunity Centers of Excellence.

Arthritis Rheumatol. 2018 Sep;70(9):1470-1480. doi: 10.1002/art.40513. Epub 2018 Jul 18.

PMID:
29604186
2.

Increased Whole Blood Viscosity Is Associated with the Presence of Digital Ulcers in Systemic Sclerosis: Results from a Cross-Sectional Pilot Study.

Korsten P, Niewold TB, Zeisberg M, Utset TO, Cho D, Zachary LS, Sweiss NJ, Volkov S.

Autoimmune Dis. 2017;2017:3529214. doi: 10.1155/2017/3529214. Epub 2017 Nov 29.

3.

X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome.

Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, Lazaro S, Weaver CA, Ice JA, Adler AJ, Chodosh J, Radfar L, Rasmussen A, Stone DU, Lewis DM, Li S, Koelsch KA, Igoe A, Talsania M, Kumar J, Maier-Moore JS, Harris VM, Gopalakrishnan R, Jonsson R, Lessard JA, Lu X, Gottenberg JE, Anaya JM, Cunninghame-Graham DS, Huang AJW, Brennan MT, Hughes P, Illei GG, Miceli-Richard C, Keystone EC, Bykerk VP, Hirschfield G, Xie G, Ng WF, Nordmark G, Eriksson P, Omdal R, Rhodus NL, Rischmueller M, Rohrer M, Segal BM, Vyse TJ, Wahren-Herlenius M, Witte T, Pons-Estel B, Alarcon-Riquelme ME, Guthridge JM, James JA, Lessard CJ, Kelly JA, Thompson SD, Gaffney PM, Montgomery CG, Edberg JC, Kimberly RP, Alarcón GS, Langefeld CL, Gilkeson GS, Kamen DL, Tsao BP, McCune WJ, Salmon JE, Merrill JT, Weisman MH, Wallace DJ, Utset TO, Bottinger EP, Amos CI, Siminovitch KA, Mariette X, Sivils KL, Harley JB, Scofield RH.

Arthritis Rheumatol. 2016 May;68(5):1290-1300. doi: 10.1002/art.39560.

4.

Perceptions of racism in healthcare among patients with systemic lupus erythematosus: a cross-sectional study.

Vina ER, Hausmann LR, Utset TO, Masi CM, Liang KP, Kwoh CK.

Lupus Sci Med. 2015 Aug 20;2(1):e000110. doi: 10.1136/lupus-2015-000110. eCollection 2015.

5.
6.

Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus.

Utset TO, Baskaran A, Segal BM, Trupin L, Ogale S, Herberich E, Kalunian K.

Lupus Sci Med. 2015 Jan 20;2(1):e000058. doi: 10.1136/lupus-2014-000058. eCollection 2015.

7.

Racial differences in treatment preferences among lupus patients: a two-site study.

Vina ER, Utset TO, Hannon MJ, Masi CM, Roberts N, Kwoh CK.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):680-8. Epub 2014 Aug 1.

PMID:
25084365
8.

Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue.

Liarski VM, Kaverina N, Chang A, Brandt D, Yanez D, Talasnik L, Carlesso G, Herbst R, Utset TO, Labno C, Peng Y, Jiang Y, Giger ML, Clark MR.

Sci Transl Med. 2014 Apr 2;6(230):230ra46. doi: 10.1126/scitranslmed.3008146.

9.

Physician-patient interactions and outcomes in systemic lupus erythematosus (SLE): a conceptual model.

Beusterien K, Bell JA, Grinspan J, Utset TO, Kan H, Narayanan S.

Lupus. 2013 Sep;22(10):1038-45. doi: 10.1177/0961203313499958.

PMID:
23963432
10.

Correlates of sleep abnormalities in systemic lupus: a cross-sectional survey in an urban, academic center.

Vina ER, Green SL, Trivedi T, Kwoh CK, Utset TO.

J Clin Rheumatol. 2013 Jan;19(1):7-13. doi: 10.1097/RHU.0b013e31827cd20d.

PMID:
23319017
11.

Significance of chronic tachycardia in systemic lupus erythematosus.

Utset TO, Ward AB, Thompson TL, Green SL.

Arthritis Care Res (Hoboken). 2013 May;65(5):827-31. doi: 10.1002/acr.21902.

12.

Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus.

Koldobskaya Y, Ko K, Kumar AA, Agik S, Arrington J, Kariuki SN, Franek BS, Kumabe M, Utset TO, Jolly M, Skol AD, Niewold TB.

Clin Dev Immunol. 2012;2012:682018. doi: 10.1155/2012/682018. Epub 2012 Jul 25.

13.

Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.

Chatham WW, Wallace DJ, Stohl W, Latinis KM, Manzi S, McCune WJ, Tegzová D, McKay JD, Avila-Armengol HE, Utset TO, Zhong ZJ, Hough DR, Freimuth WW, Migone TS; BLISS-76 Study Group.

J Rheumatol. 2012 Aug;39(8):1632-40. Epub 2012 Jun 15.

14.

A study of racial/ethnic differences in treatment preferences among lupus patients.

Vina ER, Masi CM, Green SL, Utset TO.

Rheumatology (Oxford). 2012 Sep;51(9):1697-706. doi: 10.1093/rheumatology/kes128. Epub 2012 May 30.

15.

Disease-specific patient reported outcome tools for systemic lupus erythematosus.

Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, Rodby RA, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori ML, Kosinsky M, Merrill JT, Weisman MH, Wallace DJ.

Semin Arthritis Rheum. 2012 Aug;42(1):56-65. doi: 10.1016/j.semarthrit.2011.12.005. Epub 2012 Apr 4.

PMID:
22480408
16.

Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.

Trivedi T, Franek BS, Green SL, Kariuki SN, Kumabe M, Mikolaitis RA, Jolly M, Utset TO, Niewold TB.

J Biomed Biotechnol. 2011;2011:802581. doi: 10.1155/2011/802581. Epub 2011 Oct 26.

17.

The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.

Agik S, Franek BS, Kumar AA, Kumabe M, Utset TO, Mikolaitis RA, Jolly M, Niewold TB.

J Rheumatol. 2012 Jan;39(1):73-8. doi: 10.3899/jrheum.110590. Epub 2011 Nov 1.

18.

Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.

Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M, Mikolaitis RA, Guerrero G, Utset TO, Drevlow BE, Zaacks LS, Grober JS, Cohen LM, Kirou KA, Crow MK, Jolly M, Niewold TB.

J Immunol. 2011 Aug 1;187(3):1298-303. doi: 10.4049/jimmunol.1100857. Epub 2011 Jun 24.

19.

Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.

Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR.

Arthritis Care Res (Hoboken). 2011 Jun;63(6):865-74. doi: 10.1002/acr.20441.

20.

In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis.

Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C, Kaverina N, Utset TO, Meehan SM, Quigg RJ, Meffre E, Clark MR.

J Immunol. 2011 Feb 1;186(3):1849-60. doi: 10.4049/jimmunol.1001983. Epub 2010 Dec 27.

21.

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.

Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, Green SL, Utset TO, Jolly M, James JA, Harley JB, Niewold TB.

Arthritis Rheum. 2011 Apr;63(4):1044-53. doi: 10.1002/art.30187.

22.

The lupus family registry and repository.

Rasmussen A, Sevier S, Kelly JA, Glenn SB, Aberle T, Cooney CM, Grether A, James E, Ning J, Tesiram J, Morrisey J, Powe T, Drexel M, Daniel W, Namjou B, Ojwang JO, Nguyen KL, Cavett JW, Te JL, James JA, Scofield RH, Moser K, Gilkeson GS, Kamen DL, Carson CW, Quintero-del-Rio AI, del Carmen Ballesteros M, Punaro MG, Karp DR, Wallace DJ, Weisman M, Merrill JT, Rivera R, Petri MA, Albert DA, Espinoza LR, Utset TO, Shaver TS, Arthur E, Anaya JM, Bruner GR, Harley JB.

Rheumatology (Oxford). 2011 Jan;50(1):47-59. doi: 10.1093/rheumatology/keq302. Epub 2010 Sep 23.

23.

Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.

Kariuki SN, Franek BS, Mikolaitis RA, Utset TO, Jolly M, Skol AD, Niewold TB.

J Biomed Biotechnol. 2010;2010:826434. doi: 10.1155/2010/826434. Epub 2010 Jul 4.

24.

Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.

Kariuki SN, Franek BS, Kumar AA, Arrington J, Mikolaitis RA, Utset TO, Jolly M, Crow MK, Skol AD, Niewold TB.

Arthritis Res Ther. 2010;12(4):R151. doi: 10.1186/ar3101. Epub 2010 Jul 26.

25.

Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.

Salloum R, Franek BS, Kariuki SN, Rhee L, Mikolaitis RA, Jolly M, Utset TO, Niewold TB.

Arthritis Rheum. 2010 Feb;62(2):553-61. doi: 10.1002/art.27182.

26.

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.

Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, Utset TO, Gordon C, Isenberg DA, Hsieh HJ, Zhang D, Brunetta PG.

Arthritis Rheum. 2010 Jan;62(1):222-33. doi: 10.1002/art.27233.

27.

Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.

Kariuki SN, Moore JG, Kirou KA, Crow MK, Utset TO, Niewold TB.

Genes Immun. 2009 Jul;10(5):487-94. doi: 10.1038/gene.2009.15. Epub 2009 Apr 2.

28.

Correlates of formal work disability in an urban university systemic lupus erythematosus practice.

Utset TO, Chohan S, Booth SA, Laughlin JC, Kocherginsky M, Schmitz A.

J Rheumatol. 2008 Jun;35(6):1046-52. Epub 2008 May 1.

PMID:
18464309
29.

Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus.

Booth S, Chohan S, Curran JC, Karrison T, Schmitz A, Utset TO.

Arthritis Rheum. 2007 Jun 15;57(5):845-50.

30.
31.

Neuropsychologic functioning and health status in systemic lupus erythematosus: does ethnicity matter?

Doninger NA, Fink JW, Utset TO.

J Clin Rheumatol. 2005 Oct;11(5):250-6.

PMID:
16357771
34.

Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.

Utset TO, Auger JA, Peace D, Zivin RA, Xu D, Jolliffe L, Alegre ML, Bluestone JA, Clark MR.

J Rheumatol. 2002 Sep;29(9):1907-13.

PMID:
12233885
35.

Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren's syndrome.

Utset TO, Golden M, Siberry G, Kiri N, Crum RM, Petri M.

J Rheumatol. 1994 Nov;21(11):2039-45.

PMID:
7869307

Supplemental Content

Loading ...
Support Center